Titre : Contrôle social informel

Contrôle social informel : Questions médicales fréquentes

Termes MeSH sélectionnés :

Object Attachment
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Contrôle social informel : Questions médicales les plus fréquentes", "headline": "Contrôle social informel : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Contrôle social informel : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-19", "dateModified": "2025-02-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Contrôle social informel" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Sociologie", "url": "https://questionsmedicales.fr/mesh/D012961", "about": { "@type": "MedicalCondition", "name": "Sociologie", "code": { "@type": "MedicalCode", "code": "D012961", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.880" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Contrôle du comportement", "alternateName": "Behavior Control", "url": "https://questionsmedicales.fr/mesh/D032763", "about": { "@type": "MedicalCondition", "name": "Contrôle du comportement", "code": { "@type": "MedicalCode", "code": "D032763", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.880.630.099" } } }, { "@type": "MedicalWebPage", "name": "Coercition", "alternateName": "Coercion", "url": "https://questionsmedicales.fr/mesh/D003068", "about": { "@type": "MedicalCondition", "name": "Coercition", "code": { "@type": "MedicalCode", "code": "D003068", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.880.630.200" } } }, { "@type": "MedicalWebPage", "name": "Opinion publique", "alternateName": "Public Opinion", "url": "https://questionsmedicales.fr/mesh/D011639", "about": { "@type": "MedicalCondition", "name": "Opinion publique", "code": { "@type": "MedicalCode", "code": "D011639", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.880.630.548" } } }, { "@type": "MedicalWebPage", "name": "Punition", "alternateName": "Punishment", "url": "https://questionsmedicales.fr/mesh/D011678", "about": { "@type": "MedicalCondition", "name": "Punition", "code": { "@type": "MedicalCode", "code": "D011678", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I01.880.630.716" } } } ], "about": { "@type": "MedicalCondition", "name": "Contrôle social informel", "alternateName": "Social Control, Informal", "code": { "@type": "MedicalCode", "code": "D012927", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ralf H J M Kurvers", "url": "https://questionsmedicales.fr/author/Ralf%20H%20J%20M%20Kurvers", "affiliation": { "@type": "Organization", "name": "Center for Adaptive Rationality, Max Planck Institute for Human Development, Berlin, Germany." } }, { "@type": "Person", "name": "Alhassan Abdullah", "url": "https://questionsmedicales.fr/author/Alhassan%20Abdullah", "affiliation": { "@type": "Organization", "name": "Department of Social Work and Social Administration, The University of Hong Kong, HKU Centennial Campus, PokFuLam Road, Hong Kong. Electronic address: aalhassa@connect.hku.hk." } }, { "@type": "Person", "name": "Bertrand Jayles", "url": "https://questionsmedicales.fr/author/Bertrand%20Jayles", "affiliation": { "@type": "Organization", "name": "Center for Adaptive Rationality, Max Planck Institute for Human Development, Berlin, Germany." } }, { "@type": "Person", "name": "Clifton R Emery", "url": "https://questionsmedicales.fr/author/Clifton%20R%20Emery", "affiliation": { "@type": "Organization", "name": "Department of Social Work and Social Administration, The University of Hong Kong, HKU Centennial Campus, PokFuLam Road, Hong Kong. Electronic address: cemery@hku.hk." } }, { "@type": "Person", "name": "Lucas Molleman", "url": "https://questionsmedicales.fr/author/Lucas%20Molleman", "affiliation": { "@type": "Organization", "name": "Center for Adaptive Rationality, Max Planck Institute for Human Development, Berlin, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Efficacy and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg combination in a cyclic regimen for the treatment of endometriosis-associated pain and objective gynecological findings: A multicenter, placebo-controlled, double-blind, randomized study.", "datePublished": "2024-07-11", "url": "https://questionsmedicales.fr/article/39002879", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.fertnstert.2024.07.011" } }, { "@type": "ScholarlyArticle", "name": "Comparison between residents with a 6-year medical program and a 7-year medical program in terms of objective structured clinical examination performance in postgraduate year training in Taiwan: a 2-group pre- and post-test non-synchronized study.", "datePublished": "2022-06-24", "url": "https://questionsmedicales.fr/article/35918140", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3352/jeehp.2022.19.13" } }, { "@type": "ScholarlyArticle", "name": "Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods.", "datePublished": "2022-07-15", "url": "https://questionsmedicales.fr/article/35911242", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpsyt.2022.953686" } }, { "@type": "ScholarlyArticle", "name": "The determinants associated with the prescription of a first biologic therapy in patients with axial spondyloarthritis and concomitant fibromyalgia are mostly objective and in line with the recommendations. Results of a cross-sectional survey-based study using a mixed (qualitative and quantitative) approach to help rheumatologists in their daily practice.", "datePublished": "2024-09-11", "url": "https://questionsmedicales.fr/article/39271050", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jbspin.2024.105773" } }, { "@type": "ScholarlyArticle", "name": "Subjective and Objective Improvement in a 39-Year-Old Male Suffering From Severe Chronic Pain and Disability Using Chiropractic BioPhysics® Protocols Following Rear-Impact Motor Vehicle Crash With a 10-Month Long-Term Follow-Up.", "datePublished": "2023-12-20", "url": "https://questionsmedicales.fr/article/38125689", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7759/cureus.50849" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Sciences sociales", "item": "https://questionsmedicales.fr/mesh/D012942" }, { "@type": "ListItem", "position": 3, "name": "Sociologie", "item": "https://questionsmedicales.fr/mesh/D012961" }, { "@type": "ListItem", "position": 4, "name": "Contrôle social informel", "item": "https://questionsmedicales.fr/mesh/D012927" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Contrôle social informel - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Contrôle social informel", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Contrôle social informel", "description": "Comment identifier le contrôle social informel ?\nQuels outils pour évaluer le contrôle social informel ?\nLe contrôle social informel est-il mesurable ?\nQuels signes indiquent un contrôle social informel fort ?\nPeut-on observer le contrôle social informel dans tous les groupes ?", "url": "https://questionsmedicales.fr/mesh/D012927?mesh_terms=Object+Attachment&page=741#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Contrôle social informel", "description": "Quels symptômes indiquent un contrôle social informel ?\nComment le contrôle social informel affecte-t-il les individus ?\nY a-t-il des symptômes de résistance au contrôle social ?\nLe contrôle social informel peut-il causer des troubles psychologiques ?\nQuels comportements révèlent un contrôle social informel ?", "url": "https://questionsmedicales.fr/mesh/D012927?mesh_terms=Object+Attachment&page=741#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Contrôle social informel", "description": "Comment prévenir les effets négatifs du contrôle social informel ?\nQuelles stratégies communautaires sont efficaces ?\nLe dialogue intergroupe aide-t-il ?\nComment impliquer les jeunes dans la prévention ?\nLes médias jouent-ils un rôle dans la prévention ?", "url": "https://questionsmedicales.fr/mesh/D012927?mesh_terms=Object+Attachment&page=741#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Contrôle social informel", "description": "Comment traiter les effets négatifs du contrôle social informel ?\nY a-t-il des interventions communautaires efficaces ?\nComment favoriser un contrôle social informel positif ?\nLes groupes de soutien sont-ils utiles ?\nPeut-on modifier les normes sociales ?", "url": "https://questionsmedicales.fr/mesh/D012927?mesh_terms=Object+Attachment&page=741#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Contrôle social informel", "description": "Quelles complications peuvent résulter d'un contrôle social informel excessif ?\nLe contrôle social informel peut-il mener à l'exclusion sociale ?\nY a-t-il des impacts sur la santé mentale ?\nComment le contrôle social informel affecte-t-il les relations ?\nLe contrôle social informel peut-il influencer le comportement criminel ?", "url": "https://questionsmedicales.fr/mesh/D012927?mesh_terms=Object+Attachment&page=741#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Contrôle social informel", "description": "Quels facteurs augmentent le contrôle social informel ?\nLa pauvreté influence-t-elle le contrôle social informel ?\nLes réseaux sociaux jouent-ils un rôle ?\nLes croyances culturelles influencent-elles le contrôle social ?\nComment l'éducation affecte-t-elle le contrôle social informel ?", "url": "https://questionsmedicales.fr/mesh/D012927?mesh_terms=Object+Attachment&page=741#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier le contrôle social informel ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Il se manifeste par des interactions sociales, des attentes et des sanctions au sein d'un groupe." } }, { "@type": "Question", "name": "Quels outils pour évaluer le contrôle social informel ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des enquêtes qualitatives et des observations de groupe peuvent être utilisés." } }, { "@type": "Question", "name": "Le contrôle social informel est-il mesurable ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, par des indicateurs comme la conformité aux normes et les sanctions sociales." } }, { "@type": "Question", "name": "Quels signes indiquent un contrôle social informel fort ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une forte cohésion de groupe et des comportements conformes aux attentes sociales." } }, { "@type": "Question", "name": "Peut-on observer le contrôle social informel dans tous les groupes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est présent dans presque tous les groupes sociaux, mais varie en intensité." } }, { "@type": "Question", "name": "Quels symptômes indiquent un contrôle social informel ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des comportements conformes, des pressions sociales et des sanctions pour déviance." } }, { "@type": "Question", "name": "Comment le contrôle social informel affecte-t-il les individus ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Il peut engendrer stress, conformisme ou résistance selon la perception des normes." } }, { "@type": "Question", "name": "Y a-t-il des symptômes de résistance au contrôle social ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des comportements rebelles ou des critiques des normes peuvent apparaître." } }, { "@type": "Question", "name": "Le contrôle social informel peut-il causer des troubles psychologiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une pression excessive peut mener à l'anxiété ou à la dépression." } }, { "@type": "Question", "name": "Quels comportements révèlent un contrôle social informel ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "L'adhésion aux normes, l'évitement de la déviance et la recherche d'approbation sociale." } }, { "@type": "Question", "name": "Comment prévenir les effets négatifs du contrôle social informel ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Promouvoir l'éducation sur la diversité et l'acceptation des différences." } }, { "@type": "Question", "name": "Quelles stratégies communautaires sont efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Organiser des ateliers et des discussions pour renforcer la cohésion positive." } }, { "@type": "Question", "name": "Le dialogue intergroupe aide-t-il ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il favorise la compréhension et réduit les stéréotypes entre groupes." } }, { "@type": "Question", "name": "Comment impliquer les jeunes dans la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les inclure dans des projets communautaires pour renforcer leur engagement social." } }, { "@type": "Question", "name": "Les médias jouent-ils un rôle dans la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent sensibiliser et promouvoir des comportements positifs au sein des groupes." } }, { "@type": "Question", "name": "Comment traiter les effets négatifs du contrôle social informel ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies individuelles ou de groupe peuvent aider à gérer la pression sociale." } }, { "@type": "Question", "name": "Y a-t-il des interventions communautaires efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des programmes de sensibilisation et de dialogue peuvent réduire les tensions." } }, { "@type": "Question", "name": "Comment favoriser un contrôle social informel positif ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Encourager la communication ouverte et le respect des différences au sein du groupe." } }, { "@type": "Question", "name": "Les groupes de soutien sont-ils utiles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils offrent un espace pour partager des expériences et réduire l'isolement." } }, { "@type": "Question", "name": "Peut-on modifier les normes sociales ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, par l'éducation et la sensibilisation, les normes peuvent évoluer positivement." } }, { "@type": "Question", "name": "Quelles complications peuvent résulter d'un contrôle social informel excessif ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des conflits interpersonnels, de l'anxiété et des comportements déviants peuvent survenir." } }, { "@type": "Question", "name": "Le contrôle social informel peut-il mener à l'exclusion sociale ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les individus qui ne se conforment pas peuvent être ostracisés ou marginalisés." } }, { "@type": "Question", "name": "Y a-t-il des impacts sur la santé mentale ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une pression sociale constante peut entraîner des troubles de santé mentale." } }, { "@type": "Question", "name": "Comment le contrôle social informel affecte-t-il les relations ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Il peut créer des tensions et des malentendus entre les membres d'un groupe." } }, { "@type": "Question", "name": "Le contrôle social informel peut-il influencer le comportement criminel ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des normes sociales déviantes peuvent encourager des comportements criminels." } }, { "@type": "Question", "name": "Quels facteurs augmentent le contrôle social informel ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Une forte homogénéité culturelle et des normes rigides peuvent intensifier le contrôle." } }, { "@type": "Question", "name": "La pauvreté influence-t-elle le contrôle social informel ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions socio-économiques précaires peuvent renforcer les mécanismes de contrôle." } }, { "@type": "Question", "name": "Les réseaux sociaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent amplifier les normes sociales et les pressions au sein des groupes." } }, { "@type": "Question", "name": "Les croyances culturelles influencent-elles le contrôle social ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des croyances partagées peuvent renforcer les attentes et les comportements normatifs." } }, { "@type": "Question", "name": "Comment l'éducation affecte-t-elle le contrôle social informel ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Une éducation inclusive peut réduire les stéréotypes et favoriser l'acceptation." } } ] } ] }

Sources (7405 au total)

Efficacy and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg combination in a cyclic regimen for the treatment of endometriosis-associated pain and objective gynecological findings: A multicenter, placebo-controlled, double-blind, randomized study.

To evaluate the efficacy and safety of 24-week cyclic administration of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg in Japanese patients with endometriosis.... A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.... A total of 162 Japanese women diagnosed with endometriosis.... Participants were randomly allocated to the E4/DRSP group or the placebo group. In the E4/DRSP group, participants were orally administered one tablet containing E4 15 mg and DRSP 3 mg daily for 24 da... Changes in visual analog scale scores for the most severe pelvic pain (lower abdominal and back pain) from baseline to six treatment cycles at the end of the confirmatory study period.... E4/DRSP showed changes in average visual analog scale scores for the most severe pelvic pain (-33.2 mm) from baseline to the end of the six-cycle treatment. The between-group difference was significan... E4/DRSP effectively treats endometriosis-associated pain and improves gynecological findings. E4/DRSP may be a safe, new option for endometriosis treatment with a potentially reduced risk of thromboem...

Comparison between residents with a 6-year medical program and a 7-year medical program in terms of objective structured clinical examination performance in postgraduate year training in Taiwan: a 2-group pre- and post-test non-synchronized study.

In 2013, medical schools in Taiwan implemented a 6-year medical program that replaced the previous 7-year medical education program. The postgraduate year (PGY) program was also extended from 1 year t... Of 101 residents in the PGY program at Taipei Veterans General Hospital, 78 were trained in the 6-year program, while 23 were trained in the 7-year program. During the PGY training, 2 objective struct... Residents trained in the new program scored higher on clinical reasoning (P<0.001) and the total scores of the 3 tested skills (P=0.019) on the pre-test. In terms of improvement, residents educated in... The new medical education program, which emphasizes clinical thinking, improved residents' clinical skills. The PGY program was effective in improving the clinical performance of residents who were ed...

Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods.

Cognitive side-effects are an important reason for the limited use of electroconvulsive therapy (ECT). Cognitive side-effects are heterogeneous and occur frequently in older persons. To date, insight ... The Rivastigmine for ECT-induced Cognitive Adverse effects in Late Life depression (RECALL) study combines a multicenter, prospective cohort study on older patients with depression, treated with ECT, ... This study is the first clinical trial with a focus on ECT-induced, inter-ictal delirium. The cohort provides the basis for recruitment of patients for the cross-over trial and additionally provides a... EudraCT 2014-003385-24....

The determinants associated with the prescription of a first biologic therapy in patients with axial spondyloarthritis and concomitant fibromyalgia are mostly objective and in line with the recommendations. Results of a cross-sectional survey-based study using a mixed (qualitative and quantitative) approach to help rheumatologists in their daily practice.

There is no consensus on the therapeutic strategy of rheumatologists for patients with spondyloarthritis (SpA) and concomitant fibromyalgia (FM).The main aim of this study was to identify, in a popula... This is a cross-sectional survey-based study using a mixed (qualitative and quantitative) method. The quantitative approach was web-based and conducted among rheumatologists in Normandy.... The qualitative study allowed us to identify a set of criteria likely to contribute to the therapeutic decision of rheumatologists. In the quantitative study, 54/113 rheumatologists filled the questio... The determinants associated with the decision of rheumatologists to prescribe a first bDMARD in patients with SpA/FM were mostly objective, in line with the recommendations in the literature. Most cri...